Cerebral Venous Thrombosis
Neurol Clin 10:87-111, Ameri,A.&Bousser,M-G., 1992
Stroke
Lancet 389:641-654, Hankey, G.J., 2017
Clinical Imaging Factors Associated with Infarct Progression in Patients with Ischemic Stroke During Transfer for Mechanical Thrombectomy
JAMA Neurol 74:1361-1367,1298, Boulouis, G.,et al, 2017
Comparative Effectiveness of Prestroke Aspirin on Stroke Severity and Outcome
Ann Neurol 79:560-568, Park, J.M.,et al, 2016
Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke
NEJM 372:2285-2295,2347, Saver, J.L.,et al, 2015
Thrombectomy within 8 hours after Symptom Onset in Ischemic Stroke
NEJM 372:2296-2306,2347, Jovin, T.G.,et al, 2015
Statin Use During Ischemic Stroke Hospitalization is Strongly Associated with Improved Poststroke Survival
Stroke 43:147-154, Flint, A.C.,et al, 2012
Transcranial Direct Current Stimulation in Stroke Recovery
Arch Neurol 65:1571-1576, Schlaug,G.,et al, 2008
Poststroke C-Reactive Protein Is a Powerful Prognostic Tool Among Candidates for Thrombolysis
Stroke 37:1205-1210, Montaner,J.,et al, 2006
Outcome of Acute Stroke Patients Without Visible Occlusion on Early Arteriography
Stroke 35:1135-1140, Arnold,M.,et al, 2004
Outcome of Stroke Patients without Angioigraphically Revealed Arterial Oclussion within Four Hours of Symptom Onset
AJNR 22:685-690, Derex, L.,et al, 2001
C-Reactive Protein in Ischemic Stroke
Stroke 32:917-924, De Napoli,M.,et al, 2001
C-Reactive Protein and Outcome After Ischemic Stroke
Stroke 30:981-985, Muir,K.W.,et al, 1999
Illicit Drug-Associated Ischemic Stroke in the Baltimore-Washington Young Stroke Study
Neurol 50:1688-1693, Sloan,M.A.,et al, 1998
Is Visible Infarction on Computed Tomography Associated with an Adverse Prognosis in Acute Ischemic Stroke
Stroke 29:1315-1319, Wardlaw,J.M.,et al, 1998
Complications of Acute Stroke
Lancet 339:721-724, Oppenheimer,S.&Hachinski,V., 1992
Clinicopathological Study of Pontine Hemorrhage
Stroke 14:485-493, Nakajima,K., 1983